首页> 外文期刊>Clinical & developmental immunology. >Protection against Autoimmune Diabetes by Silkworm-Produced GFP-Tagged CTB-Insulin Fusion Protein
【24h】

Protection against Autoimmune Diabetes by Silkworm-Produced GFP-Tagged CTB-Insulin Fusion Protein

机译:蚕产生的带有GFP标签的CTB-胰岛素融合蛋白对自身免疫性糖尿病的保护

获取原文
           

摘要

In animals, oral administration of the cholera toxin B (CTB) subunit conjugated to the autoantigen insulin enhances the specific immune-unresponsive state. This is called oral tolerance and is capable of suppressing autoimmune type 1 diabetes (T1D). However, the process by which the CTB-insulin (CTB-INS) protein works as a therapy for T1D in vivo remains unclear. Here, we successfully expressed a green fluorescent protein- (GFP-) tagged CTB-Ins (CTB-Ins-GFP) fusion protein in silkworms in a pentameric form that retained the native ability to activate the mechanism. Oral administration of the CTB-Ins-GFP protein induced special tolerance, delayed the development of diabetic symptoms, and suppressed T1D onset in nonobese diabetic (NOD) mice. Moreover, it increased the numbers of CD4~(+)CD25~(+)Foxp3~(+)T regulatory (Treg) cells in peripheral lymph tissues and affected the biological activity of spleen cells. This study demonstrated that the CTB-Ins-GFP protein produced in silkworms acted as an oral protein vaccine, inducing immunological tolerance involving CD4~(+)CD25~(+)Foxp3~(+)Treg cells in treating T1D.
机译:在动物中,口服与自身抗原胰岛素缀合的霍乱毒素B(CTB)亚基可增强特定的免疫无反应状态。这被称为口服耐受,并且能够抑制自身免疫性1型糖尿病(T1D)。但是,CTB胰岛素(CTB-INS)蛋白作为体内T1D疗法的过程尚不清楚。在这里,我们以五聚体形式成功地在蚕中表达了绿色荧光蛋白-(GFP-)标签的CTB-Ins(CTB-Ins-GFP)融合蛋白,该蛋白保留了激活该机制的天然能力。在非肥胖糖尿病(NOD)小鼠中,口服CTB-Ins-GFP蛋白诱导了特殊的耐受性,延迟了糖尿病症状的发展,并抑制了T1D发作。此外,它增加了外周淋巴组织中CD4〜(+)CD25〜(+)Foxp3〜(+)T调节(Treg)细胞的数量,并影响了脾细胞的生物学活性。这项研究表明,家蚕中产生的CTB-Ins-GFP蛋白可作为口服蛋白疫苗,诱导涉及CD4〜(+)CD25〜(+)Foxp3〜(+)Treg细胞的免疫耐受,从而治疗T1D。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号